Skip to main content

Table 2 System suitability and system repeatability results

From: Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form

Parameters

TLS

RST

Acceptance criteria

Retention time (min)

2.553

4.505

USP plate counts

2917

8288

 > 2000

USP tailing factor

1.44

1.23

NMT 2.0

USP resolution

9.40

NLT 2.0

% RSD of five replicate injections of standard 1

1.67

1.52

 ≤ 2.0%

The % RD between two standards

0.75

0.51

 ≤ 2.0%